Author/Creator: Yan, Bingfang - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Yan, Bingfang

1. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma12. Issue 4 (15th February 2013)

Authors:: Chen, Yuan; Song, Xiulong; Valanejad, Leila; Vasilenko, Alexander; More, Vijay; Qiu, Xi; Chen, Weikang; Lai, Yurong; Slitt, Angela; Stoner, Matthew; Yan, Bingfang; Deng, Ruitang
Journal:: Hepatology
Issue:: Volume 57:Issue 4(2013:Apr.)
Page Start:: 1530
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Dechlorination and demethylation of ochratoxin A enhance blocking activity of PXR activation, suppress PXR expression and reduce cytotoxicity. (10th October 2020)

Authors:: Shen, Yuanjun; Shi, Zhanquan; Fan, Jun Ting; Yan, Bingfang
Journal:: Toxicology letters
Issue:: Volume 332(2020)
Page Start:: 171
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin‐deficient mice. (29th November 2014)

Authors:: Xu, Jialin; Donepudi, Ajay C.; More, Vijay R.; Kulkarni, Supriya R.; Li, Liya; Guo, Liangran; Yan, Bingfang; Chatterjee, Tapan; Weintraub, Neal; Slitt, Angela L.
Journal:: Obesity
Issue:: Volume 23:Number 2(2015:Feb.)
Page Start:: 335
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Enhanced reactive oxygen species through direct copper sulfide nanoparticle-doxorubicin complexation. (22nd November 2017)

Authors:: Li, Yajuan; Cupo, Michela; Guo, Liangran; Scott, Julie; Chen, Yi-Tzai; Yan, Bingfang; Lu, Wei
Journal:: Nanotechnology
Issue:: Volume 28:Number 50(2017)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Gemcitabine nanoparticles promote antitumor immunity against melanoma. (January 2019)

Authors:: Zhang, Yuan; Bush, Xin; Yan, Bingfang; Chen, Justin A.
Journal:: Biomaterials
Issue:: Volume 189(2019)
Page Start:: 48
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation. (1st April 2015)

Authors:: Chen, Yi-Tzai; Trzoss, Lynnie; Yang, Dongfang; Yan, Bingfang
Journal:: Toxicology
Issue:: Volume 330(2015)
Page Start:: 55
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation. (1st April 2015)

Authors:: Chen, Yi-Tzai; Trzoss, Lynnie; Yang, Dongfang; Yan, Bingfang
Journal:: Toxicology
Issue:: Volume 330(2015)
Page Start:: 55
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Regulation of carboxylesterase‐2 expression by p53 family proteins and enhanced anti‐cancer activities among 5‐fluorouracil, irinotecan and doxazolidine prodrug. (25th March 2013)

Authors:: Xiao, Da; Yang, Dongfang; Guo, Liangran; Lu, Wei; Charpentier, Margaret; Yan, Bingfang
Journal:: British journal of pharmacology
Issue:: Volume 168:Number 8(2013:Apr.)
Page Start:: 1989
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Remdesivir potently inhibits carboxylesterase‐2 through covalent modifications: signifying strong drug‐drug interactions. (6th January 2021)

Authors:: Shen, Yue; Eades, William; Yan, Bingfang
Journal:: Fundamental & clinical pharmacology
Issue:: Volume 35:Number 2(2021)
Page Start:: 432
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity. Issue 9 (16th July 2021)

Authors:: Shen, Yue; Eades, William; Yan, Bingfang
Journal:: Hepatology communications
Issue:: Volume 5:Issue 9(2021)
Page Start:: 1622
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗